(Q38056878)

English

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption

scientific article published on January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption (English)

1 reference

Europe PubMed Central

27 August 2017

author name string

Yoshihisa Shitara

1

1 reference

Europe PubMed Central

27 August 2017

Kazuya Maeda

2

1 reference

Europe PubMed Central

27 August 2017

Kazuaki Ikejiri

3

1 reference

Europe PubMed Central

27 August 2017

Kenta Yoshida

4

1 reference

Europe PubMed Central

27 August 2017

Toshiharu Horie

5

1 reference

Europe PubMed Central

27 August 2017

Yuichi Sugiyama

6

1 reference

Europe PubMed Central

27 August 2017

publication date

1 January 2013

1 reference

Europe PubMed Central

27 August 2017

Biopharmaceutics and Drug Disposition

1 reference

Europe PubMed Central

27 August 2017

34

1 reference

Europe PubMed Central

27 August 2017

45-78

1 reference

Europe PubMed Central

27 August 2017

1

1 reference

Europe PubMed Central

27 August 2017

Membrane transporters in drug development

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Impact of drug transporter studies on drug discovery and development

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The SLC22 drug transporter family

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Carrier-mediated intestinal transport of drugs

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Oral drug delivery utilizing intestinal OATP transporters

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Transporters as a determinant of drug clearance and tissue distribution

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Scientific perspectives on drug transporters and their role in drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The superfamily of organic anion transporting polypeptides

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3/abcc3).

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Intestinal first-pass metabolism of CYP3A4 substrates

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Comparative pharmacophore modeling of organic anion transporting polypeptides: a meta-analysis of rat Oatp1a1 and human OATP1B1.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Clearance concepts in pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Altered Hepatic Blood Flow and Drug Disposition1

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Comparative use of isolated hepatocytes and hepatic microsomes for cytochrome P450 inhibition studies: transporter-enzyme interplay.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Kinetic characterization of rat hepatic uptake of 16 actively transported drugs

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Impact of OATP transporters on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Prediction of the effects of genetic polymorphism on the pharmacokinetics of CYP2C9 substrates from in vitro data

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Drug-drug interaction between pitavastatin and various drugs via OATP1B1.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Transporter-mediated drug--drug interactions involving OATP substrates: predictions based on in vitro inhibition studies.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Interactions of green tea catechins with organic anion-transporting polypeptides

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Intestinal drug transporter expression and the impact of grapefruit juice in humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effects of grapefruit juice on the pharmacokinetics of acebutolol

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Grapefruit juice ingestion significantly reduces talinolol bioavailability

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Clinical pharmacology of bosentan, a dual endothelin receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of torasemide

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug inter

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Saquinavir. Clinical pharmacology and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effects of uremic toxins on hepatic uptake and metabolism of erythromycin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Uptake mechanism of pitavastatin, a new inhibitor of HMG-CoA reductase, in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

1 reference

https://api.crossref.org/works/10.1002%2FBDD.1823

21 January 2018

Identifiers

10.1002/BDD.1823

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38056878&oldid=1738864351"